VIVS peer analysis
VivoSim Labs (VIVS) against its competitors: price, today's move, 1-year return and market value side by side.
VIVS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| IBO Impact BioMedical | $6.17 | 25.66% | 8.89% | $53.31M |
| KTTA Pasithea Therapeutics | $0.48 | -5.85% | 1.07% | $17.68M |
| PLRZ Polyrizon | $10.17 | -7.84% | 141.45% | $11.39M |
| PMCB PharmaCyte Biotech | $4.56 | -15.08% | -66.39% | $48.95M |
| QNRX Quoin Pharmaceuticals | $3.36 | -5.64% | -81.52% | $6.75M |
| RADX Radiopharm | $0.67 | -1.76% | -85.09% | $866.96K |
| TCRT Alaunos Therapeutics | $1.72 | 8.18% | -48.04% | $5.92M |
| XTLB XTL Biopharmaceuticals | $1.48 | -3.90% | -59.78% | $1.40M |
| VIVS VivoSim Labs | $0.29 | 142.92% | -86.38% | $4.83M |
- VIVS's peers: IBO (Impact BioMedical), KTTA (Pasithea Therapeutics), PLRZ (Polyrizon), PMCB (PharmaCyte Biotech), QNRX (Quoin Pharmaceuticals), RADX (Radiopharm), TCRT (Alaunos Therapeutics), XTLB (XTL Biopharmaceuticals).
Updated 2026-11-20 21:45 UTC